Greenbrook TMS NeuroHealth Centers in Philadelphia, PA offers FDA-cleared non-medication depression treatments such as NeuroStar® TMS Therapy and SPRAVATO® (esketamine). These treatments provide non-invasive options with minimal side effects, covered by most insurance plans including Medicare and Medicaid at various locations.
Patients can benefit from treatments that are tailored to fit into their existing regimen, whether as stand-alone therapies or in conjunction with current medications. The center's dedicated team works directly with insurance companies to ensure coverage, handle paperwork, and facilitate claims processing, making the treatment process smoother for patients.
With a focus on remission from depression, Greenbrook TMS NeuroHealth Centers aims to change the way depression is treated. Patients have shared positive testimonials about their experiences, highlighting the effectiveness of the treatments in alleviating symptoms and improving their quality of life.
Generated from the website content